Nephrectomy after HIF-2α antagonist therapy is feasible and safe. Renal surgery following or during exposure to a HIF-2α antagonist appears safe and feasible, with perioperative transfusion rates and ...
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer. Treatment ...
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor ...
Boston – For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
The researchers found that preoperative hypertension, dialysis, and steroid use were most common. HealthDay News – Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis ...
Dr. Hyung L. Kim discusses how the addition of cytoreductive nephrectomy to ICI therapy may affect survival and quality of life those with kidney cancer. A cytoreductive nephrectomy is a surgery which ...
LOUISVILLE, Ky. -- Minimally invasive ablative therapy for early kidney cancer had an increased risk of local and metastatic recurrence, which is associated with increased mortality, Swedish ...
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
Minimally invasive surgery linked to lower major complication risk, reduced length of stay, decreased transfusion rate. (HealthDay News) – Major complications occur in 7.0 percent of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results